Director, Value Strategy & Marketing

Amgen•Thousand Oaks, CA

2d•$208,320 - $281,844

About The Position

Amgen has an exciting opportunity for an experienced U.S. Value & Access leader to lead Value Strategy & Marketing across the Rare Disease and Oncology portfolio. The Director will connect payer insights, evidence strategy, value communication, and customer engagement to support sustainable coverage and patient access across inline, launch, and pipeline assets. The Rare Disease portfolio includes TAVNEOS, TEPEZZA, UPLIZNA, and KRYSTEXXA; priority Oncology assets include LUMAKRAS, IMDELLTRA, xaluritamig, and future oncology biosimilar assets. The Director will lead a team of two Senior Managers and serve as a senior strategic partner across Brand, Coverage & Pricing, Market Access, Medical Value & Population Health (MVPH), HEOR, Center for Observational Research (CfOR), U.S. Medical, Patient Access, Insights, Trade, and Global Value & Access. The role is accountable for setting portfolio priorities, building differentiated payer value strategies, and ensuring the team focuses resources on the access opportunities that matter most.

Requirements

Doctorate degree & 4 years of commercial experience OR Master’s degree & 7 years of commercial experience OR Bachelor’s degree & 9 years of commercial experience

Nice To Haves

8+ years of pharmaceutical or biotechnology industry experience, including significant U.S. market access, payer marketing, value strategy, or related Value & Access responsibility.
Demonstrated experience developing payer, value, reimbursement, or market access strategies for specialty pharmaceutical products; Rare Disease and/or Oncology experience strongly preferred.
People leadership experience with a demonstrated ability to coach, develop, and prioritize work across a high-performing team.
Strong understanding of U.S. payer decision making across medical and pharmacy benefits, including medical policy, utilization management, specialty distribution, site of care, and reimbursement for physician-administered therapies.
Launch and lifecycle-management experience, including the ability to anticipate future market dynamics and translate them into access implications.
Demonstrated ability to synthesize payer insights, clinical evidence, health economic evidence, and real-world data into differentiated value strategies and executive recommendations.
Experience influencing evidence-generation priorities and partnering effectively with HEOR, observational research, Medical, Brand, Market Access, and Coverage & Pricing teams.
Strong business acumen, strategic judgment, analytical capability, and ability to manage multiple complex workstreams in a matrixed environment.
Demonstrated aptitude for generative AI and emerging technologies, with the ability to apply them responsibly to improve strategic thinking, productivity, and organizational effectiveness.
Strong executive communication and presentation skills; advanced degree such as MBA, MPH, PharmD, PhD, or another relevant graduate degree preferred.

Responsibilities

Lead portfolio value strategy across Rare Disease and Oncology, translating brand objectives, payer dynamics, competitive change, and access barriers into clear priorities and actionable strategies.
Define differentiated payer value propositions for priority assets and ensure clinical, economic, real-world, and population-level evidence is translated into credible customer value stories.
Guide U.S. payer-relevant evidence strategy with HEOR, CfOR, Medical, Brand, and Insights; identify evidence gaps and shape studies intended to defend coverage, improve quality of coverage, and support appropriate patient identification and treatment.
Ensure payer and reimbursement considerations are integrated early into launch, indication-expansion, and lifecycle planning, including medical-benefit, pharmacy-benefit, site-of-care, specialty distribution, and utilization-management dynamics.
Partner with Market Access and MVPH leadership to shape customer engagement priorities, prepare for high-value payer and health-system discussions, and translate field insights into broader portfolio actions.
Partner with Coverage & Pricing to ensure value strategy complements coverage, pricing, contracting, and reimbursement strategies while maintaining clear functional accountability.
Oversee development and deployment of payer value resources, including payer customer value aids (CVAs), economic tools, RWE communications, health care economic information (HCEI) and pre-approval information exchange (PIE) resources where appropriate, payer FAQs, training, and customer-specific materials.
Lead, coach, and develop two Senior Managers; establish clear portfolio ownership, operating rhythms, and expectations for strategic thinking, cross-functional leadership, and executional excellence.
Champion AI-enabled ways of working across Value Strategy & Marketing, using approved AI tools to accelerate insight synthesis, evidence translation, strategic development, content creation, and team productivity.
Build AI capability across the team by identifying high-value use cases, encouraging responsible experimentation, sharing best practices, and ensuring adherence to company policies, privacy, compliance, and review requirements.
Manage portfolio budgets, agency relationships, and investment priorities; allocate resources to the highest-value strategic opportunities and establish measures of impact.
Communicate opportunities, risks, tradeoffs, and recommendations with clarity to senior leadership and drive alignment across a complex matrix.